Finding better ways to fill gaps in pediatric health research

Pediatrics

Volumn 133, Issue 4, 2014, Pages

  Viergever, Roderik F ^a,b   Rademaker, Carin M A ^c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Children; Clinical trials; Pediatric medicines; Priority setting; R and D; Research gaps

Indexed keywords

CLINICAL RESEARCH; FUNDING; HEALTH CARE ORGANIZATION; MEDICAL ETHICS; MEDICAL RESEARCH; METHODOLOGY; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

CHILDREN; CLINICAL TRIALS; PEDIATRIC MEDICINES; PRIORITY SETTING; R&D; RESEARCH GAPS;

BIOMEDICAL RESEARCH; CHILD; HUMANS; PEDIATRICS;

EID: 84898745578     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-1207     Document Type: Review

References (7)

1. Boots I, Sukhai RN, Klein RH, et al. Stimulation programs for pediatric drug research -do children really benefit? Eur J Pediatr. 2007;166(8):849-855
2. Bourgeois FT, Murthy S, Pinto C, Olson KL, Ioannidis JPA, Mandl KD. Pediatric versus adult drug trials for conditions with high pediatric disease burden. Pediatrics. 2012;130(2):285-292
3. The European Medicines Agency with its Paediatric Committee. 5-year Report to the European Commission: General report on the experience acquired as a result of the application of the Paediatric Regulation (EMA/428172/2012). London, United Kingdom: European Medicines Agency; 2012
4. Røttingen J-A, Regmi S, Eide M, et al. Mapping available health R&D data: what's there, what's missing and what role for a global observatory. Lancet. 2013;382(9900):1286-1307
5. Viergever RF, Terry RF, Karam G. Use of data from registered clinical trials to identify gaps in health research and development. Bull World Health Organ. 2013;91(6):416-425C
6. Viergever RF. The mismatch between the health research and development (R&D) that is needed and the R&D that is undertaken: an overview of the problem, the causes, and solutions. Glob Health Action. 2013;6:22450
7. Murray CJL, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics. Lancet. 2012;380(9859):2063-2066